Interpreting Vessel Diameter Changes in Vascular Headaches

Dahl E Russell D Nyberg-Hansen R Rootwelt K Cluster headache: transcranial Doppler ultrasound and rCBF studies. Cephalalgia 1990;10:87–94

Wolff HG Headache and other head pain. New York:Oxford University Press,1963

Lance JW The cephalgias, with special reference to vascular and muscle-contraction headaches. In: Goldensohn ES Appel SH edsScientific approaches to clinical neurology. Phila PA:Lea and Febiger 1977:1958 77

Humphrey PPA Apperley E Feniuk W Perren MJ A rational approach to identifying a fundamentally new drug for the treatment of migraine. In: Saxena PR Wallis DI Wouters W Vevan P eds.Cardiovascular pharmacology of 5-hydroxytryptamine. Kluwer Academic Publishers, 1991:417 31

Moskowitz MA Neurobiology of vascular head pain. Ann Neurol 1984;4:157–68

Moskowitz MA In: Mathews N edBasic mechanisms of headache. Neurol Clin North Am 1990;8:801–15

Moskowitz MA Brody M L-Y Liu-Chen In vitro release of immunoreactive substance P from putative afferent nerve endings in bovine pia arachnoid. Neuroscience 1983;9:809–14

Buzzi MG Carter B Moskowitz MA Shimizu T Heath HH III Dihydroergotamine and sumatriptan attenuate the increase in plasma CGRP levels within rat superior sagittal sinus during electrical trigeminal stimulation. Neuropharmacology 1991;30:1193–200

Goadsby PJ Edvinsson L Ekman R Vasoactive peptide release in the extracerebral circulation of man during activation of the trigeminovascular system. Ann Neurol 1988;23:193–6

Goadsby PJ Edvinsson L Ekman R Vasoactive peptide release in the extracerebral circulation of humans during migraine headache.Ann Neurol 1990;28:I83–7

Moskowitz MA The visceral organ brain: implications for the pathophysiology of vascular head pain. Neurology 1991;41:182–6

Connor HE Feniuk W Humphrey PPA Characterization of 5-HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5-HT₁-like receptor agonist. Br J Pharamcol 1988;96:379–87

Feniuk W Humphrey PPA Penin MJ The selective carotid arterial constrictor action of GR43175 in anesthetised dogs. Br J Pharmacol 1989;96:83–90

Buzzi MG Moskowitz MA The antimigraine drug, sumatriptan (GR43175), specifically blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol 1990;99:202–6

Buzzi MG Moskowtiz MA Peroutka SJ Byun B Further characterization of the 5-HT receptor that mediates inhibition of neurogenic plasma extravasation in rat dura mater. Br J Pharmacol 1991;103:1421–8

Nozaki K Boccalini P Moskowitz MA Sumatriptan and CP-93, 129 block c-fos expression in trigeminal nucleus caudalis caused by subarachnoid blood.Submitted

Goadsby PJ Edvinsson L Sumatriptan reverses the changes in calcitonin gene-related peptide seen in the headache phase of migraine. Cephalalgia 1991;11(suppl 11):3

Dimitriadou V Buzzi MG Moskowitz MA Theoharides TC Trigeminal sensory fiber stimulation induces morphological changes in rat dura mater mast cells. Neuroscience 1991;44:97–112

Dimitriadou V Buzzi MG Theoharides T Moskowitz MA Ultrastructural evidence for permeability and neuroinflammatory changes within the dura mater and tongue after trigeminal sensory fiber stimulation. Neuroscience(in press)

Buzzi MG Dimitriadou V Theoharides T Moskowitz MA 5-HT₁ agonists for vascular headaches block endothelial, mast cell and platelet activation within dura mater after trigeminal stimulation.Submitted

Presley RW Menetry D Levine JD Basbaum AI Systemic morphine suppresses noxious stimulus-evoked c-fos protein-like immunoreactivity in rat spinal cord. J Neurosci 1990;10:323–35

Diener HC Haab J Peters C Reid S Dichgans J Pilgrim A Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache. Headache 1991;31:205–9